Jones Trading Assumes Monopar Therapeutics (MNPR) at Buy

Jones Trading analyst Boris Peaker assumes coverage on Monopar Therapeutics (NASDAQ: MNPR) with a Buy rating and a price target of $130.00.

For an analyst ratings summary and ratings history on Monopar Therapeutics click here. For more ratings news on Monopar Therapeutics click here.

Shares of Monopar Therapeutics closed at $55.13 yesterday.

You May Also Be Interested In

• Monopar Therapeutics (MNPR) PT Raised to $133 at BTIG
• JPMorgan Assumes Bravura Solutions Ltd (BVS:AU) at Neutral
• Citi Starts China International Marine Containers A (000039:CH) at Buy